CAS Number: 202825-46-5
EC Number: 606-485-0
Molecular Weight: 398.5
Chemical Formula: C₁₈H₂₃FN₂O₅S
IUPAC Name: (2S)-2-[[4-[(3-fluorophenyl)methoxy]phenyl]methylamino]propanamide;methanesulfonic acid
Status: Pipeline
Therapeutic cat.: Neurology
Polymorphic form: Crystalline anhydrous form A1

Autres informations

Description supplémentaire:

Safinamide methanesulfonate (CAS 202825-46-5) is a pharmaceutical-grade central nervous system drug ingredient manufactured directly by Polpharma in crystalline anhydrous Form A1, with samples available. It is a monoamine oxidase type B (MAO-B) inhibitor that extends dopamine activity in the brain, given together with levodopa and carbidopa to treat 'wearing-off' episodes of muscle stiffness and loss of muscle control in Parkinson's disease patients; note that in patent-protected markets such as Poland, the supplier states this product is developed only for regulatory/R&D purposes or export to non-EU countries under SPC exemption, not general sale. It is offered across North America, Central/South America, Western and Eastern Europe, Australasia, Asia, the Middle East, and Africa.